» Articles » PMID: 30619239

Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?

Overview
Journal Front Immunol
Date 2019 Jan 9
PMID 30619239
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The terms microparticles (MPs) and microvesicles (MVs) refer to large extracellular vesicles (EVs) generated from a broad spectrum of cells upon its activation or death by apoptosis. The unique surface antigens of MPs/MVs allow for the identification of their cellular origin as well as its functional characterization. Two basic aspects of MP/MV functions in physiology and pathological conditions are widely considered. Firstly, it has become evident that large EVs have strong procoagulant properties. Secondly, experimental and clinical studies have shown that MPs/MVs play a crucial role in the pathophysiology of inflammation-associated disorders. A cardinal feature of these disorders is an enhanced generation of platelets-, endothelial-, and leukocyte-derived EVs. Nevertheless, anti-inflammatory effects of miscellaneous EV types have also been described, which provided important new insights into the large EV-inflammation axis. Advances in understanding the biology of MPs/MVs have led to the preparation of this review article aimed at discussing the association between large EVs and inflammation, depending on their cellular origin.

Citing Articles

Size distribution of extracellular vesicles in pretreatment ascites and plasma is correlated with primary treatment outcome in advanced high-grade serous carcinoma.

Herzog M, Verdenik I, Kobal B, cerne K Sci Rep. 2025; 15(1):4500.

PMID: 39915670 PMC: 11802836. DOI: 10.1038/s41598-025-88707-9.


Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma.

Bienes K, Yokoi A, Kitagawa M, Kajiyama H, Thaysen-Andersen M, Andersen M BBA Adv. 2025; 7:100140.

PMID: 39911812 PMC: 11794167. DOI: 10.1016/j.bbadva.2025.100140.


Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites.

Teng Y, Luo C, Qiu X, Mu J, Sriwastva M, Xu Q Nat Commun. 2025; 16(1):1295.

PMID: 39900923 PMC: 11790884. DOI: 10.1038/s41467-025-56498-2.


Tailoring cell-inspired biomaterials to fuel cancer therapy.

Wang Q, Cheng S, Han C, Yang S, Gao S, Yin W Mater Today Bio. 2025; 30:101381.

PMID: 39742146 PMC: 11683242. DOI: 10.1016/j.mtbio.2024.101381.


The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential.

Najdaghi S, Davani D, Fouladseresht H, Ebrahimi N, Sullman M, Moradi M Cell Mol Neurobiol. 2024; 44(1):82.

PMID: 39625540 PMC: 11614997. DOI: 10.1007/s10571-024-01518-w.


References
1.
Kailashiya J . Platelet-derived microparticles analysis: Techniques, challenges and recommendations. Anal Biochem. 2018; 546:78-85. DOI: 10.1016/j.ab.2018.01.030. View

2.
Lopez P, Rodriguez-Carrio J, Martinez-Zapico A, Caminal-Montero L, Suarez A . Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity. Int J Cardiol. 2017; 236:138-144. DOI: 10.1016/j.ijcard.2017.02.107. View

3.
Xie R, Yang Y, Zhu Y, Gao L, Jiang X, Sun J . Microparticles in red cell concentrates prime polymorphonuclear neutrophils and cause acute lung injury in a two-event mouse model. Int Immunopharmacol. 2017; 55:98-104. DOI: 10.1016/j.intimp.2017.11.029. View

4.
Deppermann C, Kubes P . Start a fire, kill the bug: The role of platelets in inflammation and infection. Innate Immun. 2018; 24(6):335-348. PMC: 6830908. DOI: 10.1177/1753425918789255. View

5.
Ceroi A, Angelot Delettre F, Marotel C, Gauthier T, Asgarova A, Biichle S . The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica. 2015; 101(3):e72-6. PMC: 4815731. DOI: 10.3324/haematol.2015.135459. View